Spero Therapeutics (STU:2HA) PB Ratio

: 0.70 (As of Today)

View and export this data going back to 2019. Start your Free Trial

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-23), Spero Therapeutics's share price is €1.302. Spero Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was €1.85. Hence, Spero Therapeutics's PB Ratio of today is 0.70.

Good Sign:

Spero Therapeutics Inc stock PB Ratio (=0.69) is close to 1-year low of 0.68

The historical rank and industry rank for Spero Therapeutics's PB Ratio or its related term are showing as below:

STU:2HA' s PB Ratio Range Over the Past 10 Years
Min: 0.49 Med: 2.12 Max: 6.3
Current: 0.69

During the past 9 years, Spero Therapeutics's highest PB Ratio was 6.30. The lowest was 0.49. And the median was 2.12.

STU:2HA's PB Ratio is ranked better than
86.74% of 1312 companies
in the Biotechnology industry
Industry Median: 2.335 vs STU:2HA: 0.69

During the past 12 months, Spero Therapeutics's average Book Value Per Share Growth Rate was 39.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -23.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -23.70% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Spero Therapeutics was -8.50% per year. The lowest was -28.00% per year. And the median was -24.75% per year.

Back to Basics: PB Ratio

Spero Therapeutics PB Ratio Historical Data

The historical data trend for Spero Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spero Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

2.62

4.42

5.51

1.15

0.70

Spero Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
PB Ratio																1.15	1.13	1.32	1.19	0.70

Competitive Comparison

For the Biotechnology subindustry, Spero Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spero Therapeutics PB Ratio Distribution

For the Biotechnology industry and Healthcare sector, Spero Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Spero Therapeutics's PB Ratio falls into.

Spero Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Spero Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	1.302	/	1.849
	=	0.70

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Spero Therapeutics (STU:2HA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Spero Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Spero Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Spero Therapeutics (STU:2HA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spero Therapeutics Inc (STU:2HA) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

SPRO:USA

Address

675 Massachusetts Avenue, 14th Floor, Cambridge, MA, USA, 02139

Website

https://www.sperotherapeutics.com

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Spero Therapeutics (STU:2HA) Headlines

No Headlines